Cancer News

According to a study from St. Jude’s Children’s Research Hospital, childhood cancer survivors who received cranial radiation treatment were more likely to be obese later in life. Ten years or more after receiving treatment, 47% of survivors who received cranial radiation were obese.

People who received treatment for Hodgkin lymphoma are at an increased risk of cardiovascular or heart disease throughout their lifetime according to a new study. The cumulative risk of any type of cardiovascular disease was 50% after 40 years.

According to a new study, when 49 at-risk patients were given the option to do a comprehensive cancer gene screening, one-third declined testing. Of those that declined testing, patients cited concern for uncertainty and potential distress as reasons for opting out.

Many women receiving breast reconstruction after a mastectomy for breast cancer will need more than one operation. According to a survey of 4,000 women, 88% needed two operations, 65% needed more than two, and 39% more than four.

The U.S. Food and Drug Administration approved ramucirumab for use in combination with the FOLFIRI regimen (leucovorin, fluorouracil, irinotecan). The combination is approved for patients with advanced colorectal cancer whose disease progressed while receiving first line treatment.

According to a small clinical trial from Israel, a new breath test may be able to identify the early signs of stomach cancer. When stomach cancer is present, the levels of particular compounds in exhaled breath change, and this test may be able to identify these changes.

The findings of a phase II clinical trial show that an experimental immunotherapy may be able to target an individual’s ovarian tumor and extend the time period between initial treatment and the cancer’s return for late stage ovarian cancer patients.

The U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application for carfilzomib injections for the treatment of relapsed multiple myeloma for patients who have already received at least one prior treatment.